Protecting the environment

When we challenge our impact on the environment,

We advance ways to protect it

HeartLogic™ Heart Failure Diagnostic

Boston Scientific's HeartLogic is an innovative solution for personalized and remote heart failure diagnostic and monitoring.

2% of healthcare spend

2% of healthcare spend

Heart Failure represents

A significant clinical, economic, and environmental burden. The disease accounts for 2% of healthcare spend, 60-70% of which is related to hospitalisations.1,2

Icon showing group of 3 people.

Predictive algorithm

Digital Diagnostic

HeartLogic is a digital diagnostic technology, which can be used alongside remote monitoring, in the management of heart failure patients implanted with a CRT-D or ICD device. The technology employs a predictive algorithm, to provide advanced notice of worsening heart failure.

Icon showing group of 3 people.

74% reduction in hospitalizations

Reduce hospitalizations

HeartLogic is proven to reduce hospitalizations for decompensated heart failure by 74% and hospitalization length of stay by 56%.6 This could significantly reduce resource utilization, waste per patient and greenhouse gas (GHG) emissions for the healthcare system.3,4

HeartLogic impact on GHG emissions per patient per year*


Without HeartLogic 236.5kg*


With HeartLogic 29.2kg*

This equates to a reduction of

88% In greenhouse gas emissions7

* Estimates based on rate and mean length of stay for heart failure admissions reported in Treskes et al. (2021) and data from sustainable care pathways guidance: Inpatient bed day.7 Estimates exclude impact of non-inpatient care prior to admission (e.g., primary care support or acute medical unit management), possible surgical treatment or visitors during hospital stay.

Waste Reduction


A hospital can produce more than 480 tonnes of waste each year.5

Hospital Bed

3 to 13 kg of total waste is generated per patient per bed day depending on level of acuity.4

An estimated 20-25% is plastic waste.5

An estimated 20-25% is plastic waste.5


If 1,000 heart failure patients...

HeartLogic™ heart failure diagnostics.

...were monitored using HeartLogic™ heart failure diagnostics...


…there could be a reduction of up to 71 tonnes of waste which equates to an 88% decrease in waste per 1,000 patients per year.6

What’s Next?

Boston Scientific joined the United Nations Race to Zero and Business Ambition for 1.5°C campaign and is committed to set a science-based target through the Science Based Targets initiative that will put us on a path to achieve net-zero emissions across our entire value chain by 2050.


  1. NICE Resource impact report: Chronic heart failure in adults: diagnosis and management (NG106)
  2. Cowie, Martin R. “The heart failure epidemic: a UK perspective.” Echo research and practice vol. 4,1 (2017): R15-R20.doi:10.1530/ERP-16-0043.
  3. Treskes, Roderick W., et al. "Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients.” ESC Heart Failure 8.2 (2021): 1541-1551.
  4. Sustainable Care Pathways Guidance: Inpatient bed day module published 2015, Surgical Procedure Module Published 2015 Sustainable Care Pathways Guidance – Sustainable Healthcare Coalition: (
  5. Lee, Byeong-Kyu & Ellenbecker, Michael & Moure-Eraso, Rafael. (2002). Analyses of the recycling potential of medical plastic wastes. Waste management (New York, N.Y.). 22.461-70.10.1016/S0956-053X(02)00006-5.
  6. Data on file Boston Scientific.


The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.